Download our whitepaper,

"Understanding Breast Cancer Clinical Research:
 Epidemiology, Clinical Implications & Strategies for Clinical Trial Success"

iNGENū CRO - Breast Cancer

What's Inside:

  • Key FDA-Approved Pivotal Endpoints for Breast Cancer Clinical Trials.
  • Optimizing Recruitment with Adaptive Trial Designs for Breast Cancer.
  • Comprehensive Analysis of FDA-Approved Breast Cancer Drugs.
  • How Diagnostic Criteria for Breast Cancer Have Evolved and Impact Research.
  • Overcoming Common Pitfalls in Breast Cancer Clinical Trials.
  • And additional insights to drive your trial's success.

Access your complimentary whitepaper today:

Breast Cancer

Breast cancer is a chronic and often life-threatening disease characterized by the uncontrolled growth of breast cells. It is one of the most common cancers among women worldwide, but it can also affect men.

In recent years, research has significantly advanced our understanding of breast cancer, uncovering its multifaceted nature involving genetic mutations, hormonal influences, and lifestyle and environmental factors.

This evolving knowledge has been crucial in developing current therapeutic strategies that target specific genetic mutations, utilize hormone therapy, and incorporate lifestyle and environmental management.

iNGENū's team of experienced researchers and clinicians specializes in designing and conducting innovative studies. Leveraging enhanced trial design and comprehensive patient-centric strategies, we are committed to accelerating the development of new treatments for breast cancer.

 


Breast cancer accounts for 

25%

of cancer cases in women

 

 



Women have a

12.5%

chance of developing breast cancer in their life

 


The 5-year relative survival rate for localized breast cancer is about 

99%

 


Our clinical team has over

120

years of combined clinical trial experience